Travere

Latest Posts

Practically 60% of sufferers with IgAN within the SPARTAN Examine achieved full remission when...

Market

Travere Therapeutics Presents Information Reinforcing Medical Good thing about FILSPARI ® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024...